Practice question

Answer the question and get instant feedback.

MediumRheumatologyMethotrexate Monitoringukmlamrcgp aktmrcp part 1prescribing safety assessment

A 58-year-old woman with rheumatoid arthritis, treated with methotrexate 15mg once weekly and folic acid 5mg once weekly (on a different day), presents for her routine blood monitoring. Which of the following results would be the most significant concern requiring immediate action regarding her methotrexate?

Educational content. Not a substitute for clinical judgement or local policy.